Zivvah-XT Capsule is a combination pharmaceutical formulation containing Methylcobalamin 1500 mcg and Pregabalin 75 mg, designed for the management of neuropathic pain and related neurological disorders. Methylcobalamin, an active form of vitamin B12, plays a crucial role in nerve regeneration and repair by promoting myelin sheath synthesis and enhancing neuronal function. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, exerts its therapeutic effect by modulating calcium channels in the central nervous system, thereby reducing neurotransmitter release and alleviating neuropathic pain, seizures, and anxiety. This synergistic combination is particularly effective in treating diabetic neuropathy, postherpetic neuralgia, and peripheral neuropathies, offering both symptomatic relief and neuroprotective benefits. Zivvah-XT Capsule should be administered as prescribed by a healthcare professional, with dosage adjustments based on clinical response and tolerability. Common adverse effects may include dizziness, somnolence, gastrointestinal disturbances, and peripheral edema. Caution is advised in patients with renal impairment, and it should be used judiciously in individuals with a history of hypersensitivity to either component. Regular monitoring and follow-up are recommended to optimize therapeutic outcomes and minimize potential side effects.